4//SEC Filing
Call Matthew 4
Accession 0001209191-23-021566
CIK 0001808865other
Filed
Mar 28, 8:00 PM ET
Accepted
Mar 29, 8:00 PM ET
Size
7.3 KB
Accession
0001209191-23-021566
Insider Transaction Report
Form 4
Call Matthew
Chief Operating Officer
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2023-03-28−40,226→ 107,864 totalExercise: $2.95Exp: 2029-12-04→ Common Stock (40,226 underlying) - Exercise/Conversion
Common Stock
2023-03-28$2.95/sh+40,226$118,667→ 93,898 total
Footnotes (1)
- [F1]One-fourth of the shares subject to the stock option vest on the one-year anniversary of the vesting commencement date. Thereafter, 1/48 of the shares subject to the stock option vest on a monthly basis following the one-year anniversary of the vesting commencement date, subject to the reporting person's continuous service relationship with the Issuer through each applicable vesting date.
Documents
Issuer
iTeos Therapeutics, Inc.
CIK 0001808865
Entity typeother
Related Parties
1- filerCIK 0001816207
Filing Metadata
- Form type
- 4
- Filed
- Mar 28, 8:00 PM ET
- Accepted
- Mar 29, 8:00 PM ET
- Size
- 7.3 KB